ResearcherID.com
ResearcherID
Home      Login      Search     
Hein, David W
Create a ResearcherID badge for this researcher Go to ResearcherID Labs for this researcher
Close
ResearcherID: A-9707-2008
URL: http://www.researcherid.com/rid/A-9707-2008
Keywords: pharmacogenetics; molecular epidemiology
My Institutions (more details)
Primary Institution:
Sub-org/Dept: Department of Pharmacology and Toxicology
Role:
Past Institutions: University of Wisconsin-Eau Claire; University of Michigan Medical School; Morehouse School of Medicine; University of North Dakota School of Medicine
Description:
 

Publications

My Publications (225)
 
Publication List: View
publication(s)  
First Page Previous Page Page   of  23  Go Next Page Last Page
  Sort by: 
Results per page: 
1. Title: N-ACETYLATION PHARMACOGENETICS
Author(s): WEBER, WW; HEIN, DW
Source: PHARMACOLOGICAL REVIEWS Volume: 37 Issue: 1 Pages: 25-79 Published: 1985
Times Cited: 614
added
10-Apr-08
2. Title: Metabolic gene polymorphism frequencies in control populations
Author(s): GARTE, S; GASPARI, L; ALEXANDRIE, AK; et al.
Source: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Volume: 10 Issue: 12 Pages: 1239-1248 Published: DEC 2001
Times Cited: 412
added
10-Apr-08
3. Title: Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms
Author(s): HEIN, DW; DOLL, MA; FRETLAND, AJ; et al.
Source: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Volume: 9 Issue: 1 Pages: 29-42 Published: JAN 2000
Times Cited: 358
added
10-Apr-08
4. Title: NOMENCLATURE FOR N-ACETYLTRANSFERASES
Author(s): VATSIS, KP; WEBER, WW; BELL, DA; et al.
Source: PHARMACOGENETICS Volume: 5 Issue: 1 Pages: 1-17 Published: FEB 1995
Times Cited: 322
added
10-Apr-08
5. Title: ACETYLATOR GENOTYPE AND ARYLAMINE-INDUCED CARCINOGENESIS
Author(s): HEIN, DW
Source: BIOCHIMICA ET BIOPHYSICA ACTA Volume: 948 Issue: 1 Pages: 37-66 Published: AUG 3 1988
Times Cited: 314
added
10-Apr-08
6. Title: METABOLIC-ACTIVATION AND DEACTIVATION OF ARYLAMINE CARCINOGENS BY RECOMBINANT HUMAN NAT1 AND POLYMORPHIC NAT2 ACETYLTRANSFERASES
Author(s): HEIN, DW; DOLL, MA; RUSTAN, TD; et al.
Source: CARCINOGENESIS Volume: 14 Issue: 8 Pages: 1633-1638 Published: AUG 1993
Times Cited: 260
added
10-Apr-08
7. Title: NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
Author(s): GARCIA-CLOSAS, M; MALATS, N; SILVERMAN, D; et al.
Source: LANCET Volume: 366 Issue: 9486 Pages: 649-659 Published: AUG 20 2005
Times Cited: 176
added
10-Apr-08
8. Title: Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis
Author(s): HEIN, DW
Source: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS Volume: 506 Pages: 65-77 Published: SEP 30 2002
Times Cited: 176
added
10-Apr-08
9. Title: CLINICAL PHARMACOKINETICS OF ISONIAZID
Author(s): WEBER, WW; HEIN, DW
Source: CLINICAL PHARMACOKINETICS Volume: 4 Issue: 6 Pages: 401-422 Published: 1979
Times Cited: 156
added
10-Apr-08
10. Title: A UNIQUE PHARMACOGENETIC EXPRESSION OF THE N-ACETYLATION POLYMORPHISM IN THE INBRED HAMSTER
Author(s): HEIN, DW; OMICHINSKI, JG; BREWER, JA; et al.
Source: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Volume: 220 Issue: 1 Pages: 8-15 Published: 1982
Times Cited: 123
added
10-Apr-08
publication(s)  
First Page Previous Page Page   of  23  Go Next Page Last Page
  Sort by: 
Results per page: 
© COPYRIGHT 2010
Published by Thomson Reuters